← Leaderboards
Dev Kumar Chatterjee
Fannin Partners, Llc
$622,607
Attributed
$622,607
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $567.6K · FY2017–19$1M$750K$500K$250K$0
'17
'18
'19
Funding mix
By agency
NIH$622,607 · 2
By mechanism
R43$622,607 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Novel Therapeutics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$263,124,404
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
Research focus
Novel TherapeuticsAnimal ModelTechnologyToxicologyGenesInnovationIn VivoPharmaceutical PreparationsCommercializationAdoptionExpectationApoptosisDrug KineticsExcretory FunctionAntineoplastic AgentsDrug DevelopmentExperimental StudyClinical DevelopmentBolus InfusionChemistryClinical ApplicationCancer CellDoseBlood Circulation
Grant awards (3)
Reconstituted High Density Lipoprotein Particles as siRNA Carriers$55,000
R43 · FY2019 · TR · contact PI
Reconstituted High Density Lipoprotein Particles as siRNA Carriers$324,593
R43 · FY2017 · TR · contact PI
Novel Small Molecule Targeting STAT Proteins for the Management of Atopic Dermatitis$243,014
R43 · FY2017 · AI · contact PI